SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-064230
Filing Date
2020-05-20
Accepted
2020-05-20 16:04:44
Documents
9
Period of Report
2020-05-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2020188d1_8k.htm 8-K 30943
2 EXHIBIT 1.1 tm2020188d1_ex1-1.htm EX-1.1 227150
3 EXHIBIT 4.1 tm2020188d1_ex4-1.htm EX-4.1 50815
4 EXHIBIT 5.1 tm2020188d1_ex5-1.htm EX-5.1 9996
5 EXHIBIT 10.1 tm2020188d1_ex10-1.htm EX-10.1 37013
6 EXHIBIT 99.1 tm2020188d1_ex99-1.htm EX-99.1 9898
7 EXHIBIT 99.2 tm2020188d1_ex99-2.htm EX-99.2 12144
8 GRAPHIC image_001.jpg GRAPHIC 2029
9 GRAPHIC ex5-1_logo.jpg GRAPHIC 2781
  Complete submission text file 0001104659-20-064230.txt   386105
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36845 | Film No.: 20898100
SIC: 2834 Pharmaceutical Preparations